Development of Cancer Vaccine Targeting WT1 Product which is Expressed in Various Kinds of Malignant Neoplasms

ISSN： 1567-2034

Source： Medicinal Chemistry Reviews - Online, Vol.2, Iss.6, 2005-12, pp. : 447-454

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of WT1 Peptide Cancer Vaccine Against Hematopoietic Malignancies and Solid Cancers

Current Medicinal Chemistry, Vol. 13, Iss. 20, 2006-08 ,pp. : 2345-2352

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Effective Cancer Vaccine Using Targeting System of Antigen Protein to APCs

By Kurosaki Tomoaki Kitahara Takashi Nakamura Tadahiro Nishida Koyo Fumoto Shintaro Kodama Yukinobu Nakagawa Hiroo Higuchi Norihide Sasaki Hitoshi

Pharmaceutical Research, Vol. 29, Iss. 2, 2012-02 ,pp. : 483-489

Springer Publishing Company

Access to resources Recommend Favorite

“Cancer Antigen WT1 Protein-Derived Peptide”-Based Treatment of Cancer -Toward the Further Development

Current Medicinal Chemistry, Vol. 15, Iss. 29, 2008-12 ,pp. : 3052-3061

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer vaccine development

By Schlom J. Tsang K-Y. Kantor J.A. Abrams S.I. Zaremba S. Greiner J. Hodge J.W.

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 9, 1998-09 ,pp. : 1439-1452

Informa Healthcare

Access to resources Recommend Favorite

Increased risk of second malignant neoplasms in adolescents and young adults with cancer

By Lee Jean S. DuBois Steven G. Coccia Peter F. Bleyer Archie Olin Rebecca L. Goldsby Robert E.

Cancer, Vol. 122, Iss. 1, 2016-01 ,pp. : 116-123

Blackwell Publishing

Access to resources Recommend Favorite